Elsevier

Thrombosis Research

Volume 63, Issue 2, 15 July 1991, Pages 239-248
Thrombosis Research

Paper
12-HETE inhibits the binding of PGH2/TxA2 receptor ligands in human platelets

https://doi.org/10.1016/0049-3848(91)90287-7Get rights and content

Abstract

12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE), the end-lipoxygenase product of arachidonic acid in platelets has been previously shown to prevent PGH2/TXA2-induced aggregation. From the present study, we show that 12-HETE inhibits the binding of [125I]-PTA-OH, a thromboxane antagonist, to platelet membranes with an IC50 of 8 μM. This value is in accordance with previously reported 12-HETE concentrations required to prevent the aggregation induced by TxA2 mimetics, the methano analogues of PGH2, U44069 and U46619. When [3H]-U44069 was used as a thromboxane agonist to label intact platelets, 12-HETE also inhibited its binding. We conclude that part of the inhibitory effect of 12-HETE on PGH2/TxA2-induced aggregation might be the result of interacting with PGH2/TxA2 receptor sites.

References (27)

  • K. Takahara et al.

    The reponse to thromboxane A2 analogues in human platelets

  • B. Samuelsson et al.

    Prostaglandins and Thromboxanes

    Annu. Rev. Biochem.

    (1978)
  • P. Needleman et al.

    Arachidonic acid metabolism

    Annu. Rev. Biochem.

    (1986)
  • Cited by (33)

    • Inflammatory heterogeneity in aspirin-exacerbated respiratory disease

      2021, Journal of Allergy and Clinical Immunology
      Citation Excerpt :

      Depending on the stimulus studied, 12-HETE has been shown to have promoting and suppressing effects on platelet activation.48 Notably 12-HETE interacts with the TXA2 receptor and inhibits TXA2-induced platelet aggregation.49,50 Platelets and TXA2 receptor have been identified as key factors required for inflammation in AERD.51,52

    • Oxygenation of polyunsaturated fatty acids and oxidative stress within blood platelets

      2018, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
      Citation Excerpt :

      Second, they can be esterified within platelet phospholipids, which may limit interactions with their specific receptors [53]. Although the lipoxygenase end-products are clearly inhibitors of TxA2-induced platelet aggregation, especially the mono-hydroxy derivatives 12-HETE and 14-HDoHE, their interactions with TxA2 receptor is only putative [54,55]. However, the observation that the (R) stereoisomers appear more potent than the (S) ones, e.g. 13(R)-HODE vs 13(S)-HODE, 12(R)-HETE vs 12(S)-HETE, 12(R)-HHT vs 12(S)-HHT [47], 9(R),16(S)-diOH-18:3 vs 9(S),16(S)-diOH-18:3 [36], and 10(R),17(S)-diOH-22:6 vs the 10(S),17(S)-diOH isomer named PDX [44,56], suggests that the 3D conformation of these hydroxylated derivatives might be important for antagonizing the TxA2 receptor.

    • Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI/HRMS

      2018, Journal of Lipid Research
      Citation Excerpt :

      Considering that 12(R)-HETE is synthesized by cytochrome P450 in the ocular system (27) and by 12(R)-LOX in the epidermis and tonsils (28, 29), we hypothesize that low levels of serum 12(R)-HETE are formed nonenzymatically. The role of 12(S)-HETE in platelet biology is not fully understood, with studies reporting both activation (30–32) and inhibition (33, 34) of platelet aggregation. The 12-HETE has been implicated in the pathophysiology of cancer, arteriosclerosis, and diabetes (26).

    • Functional fluxolipidomics of polyunsaturated fatty acids and oxygenated metabolites in the blood vessel compartment

      2015, Progress in Lipid Research
      Citation Excerpt :

      Those two molecules are also able to modulate platelet aggregation; 12-HpETE is an activator of both the release of ArA through cPLA2 and its oxygenation into prostanoids by stimulating the cyclooxygenase activity [22]. In contrast, the accumulation of 12-HETE may inhibit the reactivity of TxA2 [23], at the level of its receptor site [24]. The kinetics of 12-LOX is slower than that of COX, but more stable with time, meaning that the early 12-LOX activity might potentiate the TxA2-dependent aggregation whereas the later 12-LOX activity might inhibit it, as do PGD2 and the late PGE2.

    • Omega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis

      2015, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
    View all citing articles on Scopus
    View full text